ADVFN - Advanced Financial Network.
HOME» NYSE » B » BSX Stock Price » BSX Stock News

Boston Scientific Share News

 Boston Scientific Corp. Stock Price
BSX Stock Price
 Boston Scientific Corp. Stock Chart
BSX Stock Chart
 Boston Scientific Corp. Stock News
BSX Stock News
 Boston Scientific Corp. Company Information
BSX Company Information
 Boston Scientific Corp. Stock Trades
BSX Stock Trades

Federal Court Rules In Favor Of Boston Scientific In J&J Patent Case

DOW JONES NEWSWIRES A federal court ruled a stent system made by Boston Scientific Corp. (BSX) doesn't infringe on Johnson & Johnson (JNJ) patents, a judgment that helps the medical-device maker notch a win in a patent war with the health-care products giant. Johnson & Johnson had alleged in a 2008 suit that Boston Scientific's Promus everolimus-eluting coronary stent system infringed on two of its patents. Boston Scientific on Monday touted a decision from a federal court in New Jersey, saying the court had found the patents to be invalid. "Boston Scientific will continue to vigorously defend against any claims of infringement," said Tim Pratt, general counsel for the company. A spokeswoman for Johnson & Johnson couldn't immediately be reached for comment. The two companies have been locked in a long-running battle over intellectual property for heart stents, with both scoring some victories along the way. Johnson & Johnson shares were recently down slightly to $65.25 premarket, while Boston Scientific were up 1.2% to $6.05. -By Mia Lamar, Dow Jones Newswires; 212-416-3207; mia.lamar@dowjones.com

Stock News for Boston Scientific (BSX)
DateTimeHeadline
04/20/201516:01:00Long-Term Data Underscore Safety And Efficacy Of The Boston Scientific...
04/16/201516:05:00Boston Scientific Enrolls First Patient In New Study Designed...
04/14/201516:13:39Current Report Filing (8-k)
04/14/201509:00:00Boston Scientific Signs Strategic Alliance With Frankenman Medical...
04/03/201516:03:56Statement of Changes in Beneficial Ownership (4)
04/03/201516:03:56Statement of Changes in Beneficial Ownership (4)
04/02/201502:40:47First Quarter Large Cap Winners And Losers
04/01/201516:08:02Initial Statement of Beneficial Ownership (3)
04/01/201516:07:07Initial Statement of Beneficial Ownership (3)
04/01/201516:01:00Boston Scientific Agrees to Acquire Xlumena
04/01/201508:30:00Boston Scientific To Webcast Conference Call On First Quarter...
04/01/201507:32:38Is It Time To Book Profits? - Cramer's Mad Money (3/31/15)
03/24/201516:21:27Additional Proxy Soliciting Materials (definitive) (defa14a)
03/24/201516:19:15Proxy Statement (definitive) (def 14a)
03/24/201516:01:00Boston Scientific Announces First U.S. Commercial Procedures...
03/23/201519:46:25Significant Revenue Gains In Store For Boston Scientific
03/23/201516:06:44Statement of Changes in Beneficial Ownership (4)
03/23/201516:06:44Statement of Changes in Beneficial Ownership (4)
03/18/201519:15:18Boston's Watchman Approved In The US For Warfarin Refuseniks
03/17/201518:55:09Boston Sci's EMBLEM subcutaneous implantable defibrillator cleared...

Boston Scientific and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad